# Can ARA-290 mitigate nephrotoxicity in aging kidney tissue?

Canonical source: https://retacompare.com/research/can-ara-290-mitigate-nephrotoxicity-in-aging-kidney-tissue

Peptide Longevity Q&A · 2023-02-01


    ARA-290 demonstrates protective effects against cisplatin-induced nephrotoxicity by reducing oxidative stress, inflammation, and apoptosis in kidney cells. This suggests its potential role in supporting kidney health, particularly in conditions that may affect older populations.

 What the research shows

The study investigated the protective effects of ARA290, an 11-amino acid peptide, against nephrotoxicity induced by cisplatin in HEK-293 and ACHN cell models. Researchers treated the cells with varying concentrations of ARA290 (50-400 nM) and cisplatin (2.5 µM) to assess cytotoxicity, genotoxicity, oxidative stress parameters, and inflammatory markers. The study specifically evaluated oxidative stress indicators such as reactive oxygen species (ROS), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA), alongside pro-inflammatory cytokines like TNFα, IL6, and IL1β. Additionally, apoptotic cell death was measured through caspase-3 activity and TUNEL assays. The findings indicated that ARA290 significantly reduced DNA damage and improved oxidative stress parameters while also mitigating renal inflammation and apoptosis.

 Why it matters for longevity

The protective effects of ARA-290 against nephrotoxicity have significant implications for longevity and kidney health, especially in aging populations. As individuals age, the risk of kidney injury increases, often due to factors such as chronic diseases and the cumulative effects of medications like cisplatin. The ability of ARA-290 to reduce oxidative stress and inflammation could help preserve kidney function and overall healthspan, potentially leading to improved outcomes in older adults experiencing kidney-related issues. By targeting apoptosis and inflammatory pathways, ARA-290 may offer a therapeutic approach for preventing acute kidney injury and promoting tissue regeneration in aging kidneys.

 Key findings at a glance

ARA-290 reduced DNA damage and micronuclei frequency in kidney cells exposed to cisplatin.

The peptide improved oxidative stress by decreasing MDA and ROS levels and enhancing antioxidant enzyme activity.

ARA-290 significantly lowered pro-inflammatory cytokine levels associated with cisplatin treatment.

Apoptosis was reduced as indicated by decreased caspase-3 activity and increased Bcl2 expression.

The study suggests ARA-290 could be a potential therapeutic agent for acute kidney injury.

 How ARA-290 works (background)

ARA-290 is derived from the structure of erythropoietin (EPO) and selectively interacts with the innate repair receptor (IRR), which plays a crucial role in tissue protection. By binding to this receptor, ARA-290 activates protective signaling pathways that counteract oxidative stress and inflammation. The peptide's ability to modulate the expression of key proteins involved in apoptosis and inflammation, such as TNFα, IL1β, IL6, and Bcl2, underscores its potential as a therapeutic agent in conditions that lead to kidney injury.

 Safety, caveats, and what we don't yet know

While the findings indicate the nephroprotective effects of ARA-290, it is essential to recognize that this research is preclinical and conducted in cell models. The implications for human health and safety remain to be fully established. Further studies are needed to explore the peptide's efficacy in vivo, particularly in aging populations and those with existing kidney conditions. Additionally, the long-term effects and potential side effects of ARA-290 require further investigation to ensure its safety and effectiveness as a therapeutic option.

 Bottom line

ARA-290 shows promise in mitigating nephrotoxicity and supporting kidney health, particularly relevant for aging populations. Its protective effects against oxidative stress, inflammation, and apoptosis may contribute to improved kidney function in at-risk individuals.

 Related questions

 Does ARA-290 enhance tissue repair in aging kidneys?

Research suggests that ARA-290 may support tissue repair by reducing inflammation and apoptosis, which are critical factors in kidney injury recovery.

 Can ARA-290 be beneficial for chronic kidney disease?

While ARA-290 shows protective effects in preclinical models, further research is necessary to determine its benefits specifically for chronic kidney disease in humans.

 What role does ARA-290 play in oxidative stress management?

ARA-290 has been shown to reduce oxidative stress markers in kidney cells, indicating its potential role in managing oxidative damage associated with aging and injury.

 Source: PubMed · Inflammation · published 2023-02-01.

## Sources

- PubMed · Inflammation: https://pubmed.ncbi.nlm.nih.gov/36085231/